Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yeah. If someone has the time to call in for the Lightning Round on Mad Money
Was it you that got Jim Cramer going from you recent message storm? High-Fives! Lol!
Yes. It has a trusted symbol. Or, one of us hacked him! Lol!
But why repeat that over and over and over for months on end? Not you specifically, but the “board.
What I mean is what makes us think this will ever really end?
You really think it would matter 24 hours later? There is a VERY SHORT memory around here about the true value a company holds...
So much for JANE preventing games...
And Uplisting!
You should consider cross-posting this on ST. Or, say the word and I’ll do it! Another almost 15k eyeballs over there following ENZC.
Hmmm...
I was attempting to tie the NIH post to the ENZC PR (ITV-1 vs Tamiflu), but I see where your going...
Maybe. But this was recently released by the Director of the NIH. Are these clues? Only time will tell...
"Looking a bit further down the road, we also seek to develop orally administered drugs that would potentially block the replication ability of SARS-CoV-2, the coronavirus that causes COVID-19, in the earliest stages of infection. One goal would be to develop an antiviral medication for SARS-CoV-2 that acts similarly to oseltamivir phosphate (Tamiflu®), a drug used to shorten the course of the flu in people who’ve had symptoms for less than two days and to prevent the flu in asymptomatic people who may have been exposed to the influenza virus. Yet another major long-term effort of NIH and its partners will be to develop safe and effective antiviral medications that work against all coronaviruses, even those with variant genomes. (And, yes, such drugs might even cure the common cold!)"
Source: https://directorsblog.nih.gov/2021/02/16/activ-update-making-major-strides-in-covid-19-therapeutic-development/
What is your twitter @?
Jane Street Capital.
https://en.wikipedia.org/wiki/Jane_Street_Capital
Well, the NIH's mid-February grant update is out, and no Enzolytics (or Bioclonetics)...
https://report.nih.gov/award/index.cfm?ot=&fy=2021&state=&ic=&fm=&orgid=&distr=&rfa=&om=n&pid=
Yesterday was a marketable PR. It’s influence lasted 24 hours. The company has real world value in the multi dollar range, at least. This penny flipping, see saw pricing is not real work value. It’s BS.
Screenshot your post. Look at it three months from now. The same crap will be ongoing then. Mark it.
Stupid question, but aren’t the mostly disdained Market Makers like CDEL involved in most other exchanges, too?
I agree. We can’t have, nor can we expect news every day, or even every week. This company has strong value, but it cannot find it’s free market value equilibrium if it keeps getting relentlessly manipulated down (and up) daily.
I feel like Captain Obvious, here. Lol.
For info only, there is a large generator in the rear of the Texas A&M Institute For Preclinical Studies. From Google Earth. Emergency backup, or whole building power? Who knows. But, the essential stuff should be ok... Not downplaying those without power. Just another angle in the ENZC story to consider.
I am beginning to think that with today's news about toxicity tests completed in Bulgaria for the ITV-1 peptide used against an Influenza virus (and compared with Tamiflu®), with the previous news release informing us that BTS Research in San Diego is retesting the toxicity of the ITV-1 compound for the FDA's requirements, and the NIH Director's information sheet (dated today) discussing the future development of an oral COVID drug that works similar to Tamiflu®, we just may have a new class of drugs coming from a new class of small, agile Pharma companies, like our Enzolytics.
See the discussion a few paragraphs below ACTIV-5:
https://directorsblog.nih.gov/2021/02/16/activ-update-making-major-strides-in-covid-19-therapeutic-development/
Three things I know after trading for 40 years: 1. Institutional traders don’t touch penny stocks. 2. Hedge funds are not shorting penny stocks. 3. I never learn from my own mistakes.
Sure. I agree. My question was why is a dead stock, I mean completely dead even allowed transactions? This is on the exchange it was listed on. Their bad.
There is always a lot of emotion involved with trading ones own money. We are human. Of course there is a reason. We dropped from 90s to upper 40s in three days. Right, wrong, or whatever, it is a reason. The same reason there was all the crowing about joining the Milly’s Club earlier this week. Emotion.
The company hasn’t changed. Fact. As far as we know. I trade the OTC because it is never boring. But, I find I am addicted to gains. I don’t handle the drops well. But, at least I don’t sell.
And, I tried the “don’t look” solution. Ah, no. Not for me. I gotta know! Lol!
I have the same question about RSI. What is the standard interval? I can make RSI anything by changing the time interval. What standard is the accepted “Norm”? Please.
The SEC suspended SCIE. A dead company, not a shell, but a dead stock. Why was it even allowed to drift out there to trade? For years...
Yet the shady behavior continues. MMs colluding and social media driven raids, both buying and selling. Pure manipulation. At least the social media actions leave a ton of evidence for all to see if one just looks.
So, this is what the market thinks the cure for HIV is worth? $0.47?
Welcome back. We missed you.
Charles DID tell us Enzolytics are working on COVID at Texas A&M, for the record:
From: https://www.otcmarkets.com/stock/ENZC/news/Enzolytics-Inc-2020-Year-End-Update?id=284809
"Our new lab is being opened on the campus of Texas A&M University in the University's Institute for Preclinical Studies. Here we will expand our development capabilities for the production of additional monoclonal antibodies targeting immutable sites on the HIV and SARS-CoV-2 viruses. In addition to those primary targets on these viruses already known to us, we have engaged an artificial intelligence (AI) and genetics and molecular biology data science team to curate the thousands of isolates (strains) now known as existing in both the HIV virus and the SARS-CoV-2 virus. This process will allow us to identify conserved, immutable targets against which monoclonal antibodies are to be produced.
The significance of this step is well recognized by experts in virology due to the ability of all viruses to mutate and render ineffective, initially developed therapeutics. We have all now heard of the new variants of the CoronaVirus that have just surfaced this week in the United Kingdom and South Africa. Such variants have been found to now exist in the U.S. Due to mutation, these variants have slightly different structures from the virus as initially introduced into the U.S. and will require different therapeutics to address them. The necessary response to such mutations is to identify sites on the virus that do not mutate - that are immutable - and to produce monoclonal antibodies targeting these immutable sites. Using artificial intelligence, we expect to be able to identify these sites such that antibodies may be produced targeting them. This is one of our focuses."
Maybe the non DD reading mob buyers that got discouraged 15 minutes after their purchase will go somewhere else tomorrow. KNOW WHAT YOU OWN!
I am showing it at 48.65 as i type this
Wow! This board hasn't been this quiet in a LONG TIME!
Looks like the MMs may be setting up another stop loss raid.
Tell her to Google “RONALD WAYNE”. I almost cry for him every time I cross paths with his story...
https://globalnews.ca/news/5158415/apple-co-founder-ronald-wayne/
Ah, weekend FOMO. A wonderful thing!
A new avatar pic! Dramatic!
Well, I was going to complement you on the haircut!